[1]
Feng, X., Zhu, S., Yan, Z., Wang, C., Tong, W. and Xu, W. 2020. PDGFRB as a potential therapeutic target of ankylosing spondylitis: validation following bioinformatics analysis. Cellular and Molecular Biology. 66, 6 (Sep. 2020), 127–134. DOI:https://doi.org/10.14715/cmb/2020.66.6.23.